Bioxytran, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-2.1M | $-2.4M | $-4.5M | $-2.5M | $-4.0M | $-2.5M | $-1.9M | $-296.4K |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | $11.5K | $8.0K | $8.3K | $3.6K | — | $-10.0K | — | — |
| Stock-Based Compensation | — | — | $88.1K | $140.0K | $582.9K | $247.9K | $1.1M | — |
| Net Cash from Operating Activities | $-526.5K | $-381.3K | $-775.4K | $-1.8M | $-1.7M | $-1.1M | $-431.0K | $-185.9K |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-23.1K | $-28.2K | $-44.3K | $-32.2K | $-36.9K | $-10.0K | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $1.1M | $388.6K | $550.4K | $2.1M | $1.8M | $981.1K | $564.3K | $222.2K |
| Net Change in Cash | — | — | — | — | — | $-127.9K | $133.2K | $36.3K |
| Free Cash Flow | — | — | — | — | — | — | — | — |